Related Experiment Video
Updated: Feb 5, 2026

An Ex vivo Model to Study Hormone Action in the Human Breast
Published on: January 8, 2015
Development of nanoparticulate systems with action in breast and ovarian cancer: nanotheragnostics
Fabiana de Sousa Cunha1, Laise Nayra Dos Santos Pereira2, Thâmara Pryscilla de Costa E Silva2
1a Departamento de Química, Campus Poeta Torquato Neto , Universidade Estadual do Piauí , Teresina , Brazil.
Abstract:
The use of nanoparticulate systems with action in breast and ovarian cancer has been highlighted in recent years as an alternative to increasing the therapeutic index of conventional anticancer drugs. Thus, nanoparticles have advantageous characteristics in the treatment of cancer. Several nanocarriers of drugs and nanoparticles are described in the literature. The pharmacokinetics of the drugs can be modified by the use of nanocarriers, which in turn facilitate the specific delivery of the drug to the tumour cell. Therefore, the present work is a review that examines some nanosystems with nanoparticles for action in the treatment of breast cancer and ovarian cancer.
Insights
Nanoparticulate systems offer a promising approach to enhance cancer therapy by improving drug delivery and efficacy for breast and ovarian cancers. This review explores various nanosystems for improved therapeutic outcomes.
Area of Science:
- Oncology
- Nanotechnology
- Pharmacology
Background:
- Nanoparticulate systems are increasingly recognized for their potential in cancer treatment.
- Conventional chemotherapy faces challenges like limited therapeutic index and systemic toxicity.
- Nanoparticles offer unique characteristics for targeted cancer therapy.
Purpose of the Study:
- To review nanosystems utilizing nanoparticles for treating breast and ovarian cancers.
- To highlight the advantages of nanoparticles in cancer drug delivery.
- To examine how nanocarriers modify drug pharmacokinetics for targeted delivery.
Main Methods:
- Literature review of existing studies on nanoparticulate systems in cancer therapy.
- Analysis of nanocarrier drug delivery systems for breast and ovarian cancer.
- Examination of pharmacokinetic modifications induced by nanocarriers.
Main Results:
- Nanoparticles can enhance the therapeutic index of anticancer drugs.
- Nanocarriers facilitate specific drug delivery to tumor cells.
- Various nanocarrier systems are described in the literature for cancer treatment.
Conclusions:
- Nanoparticulate systems represent a significant advancement in treating breast and ovarian cancers.
- Targeted drug delivery via nanoparticles improves treatment efficacy and potentially reduces side effects.
- Further research into nanosystems holds promise for overcoming limitations in current cancer therapies.
Related Concept Videos
Fixed Action Patterns
Action Potentials
Action Potential
Membrane potential in neurons
Neurons typically have a resting membrane potential of about -70 millivolts (mV). When they receive...
Action Potential
Membrane potential in neurons
Neurons typically have a resting membrane potential of about -70 millivolts (mV). When they receive...
Ovarian Cycle
Sustainable Development

